title: Outcome of vitreoretinal surgery and penetrating keratoplasty using temporary keratoprosthesis.
abstract: OBJECTIVE
  The use of a temporary keratoprosthesis has allowed earlier surgical intervention in eyes with coexisting vitreoretinal and corneal disease. We analyzed our experience with this type of surgery.
  
  
  METHODS
  We retrospectively reviewed charts of patients in whom a temporary keratoprosthesis was used between 1987 and 1998. Analysis was focused on ocular history, indications for surgery, visual acuity (VA), intraocular pressure, anatomic results, and complications.
  
  
  RESULTS
  A temporary keratoprosthesis was used in 31 eyes, 22 (71.0%) of which were for trauma-related indications. In 6 (19.4%) of the operated eyes, the fellow eye also had severely reduced VA. Retinal detachments were present in 30 (96.8%) eyes; most had evident proliferative vitreoretinopathy. Twelve (38.7%) eyes had vitreous hemorrhage, and 20 (64.5%) had corneal scars. Improvement in VA was seen initially in 45.1% of patients, and 51.6% maintained equal or better VA at their final visit as compared with before surgery. The common documented reasons for poor final VA were recurrent retinal detachments deemed inoperable (32.3%), phthisis (22.6%), and optic atrophy or macular scar (16.1%). Corneal grafts remained clear in 41.9%. Nine patients had further surgery. The most significant complication was one case of sympathetic ophthalmia.
  
  
  CONCLUSIONS
  Combined vitreoretinal and corneal surgery using temporary keratoprostheses has been used in our institution to treat eyes with extreme abnormalities. Outcomes were less favorable than some reported in the literature, probably because of the severity of disease for which temporary keratoprostheses were reserved. Although results are probably better than the natural course of the disease, patients should be informed of realistic expectations for improvement and potential complications when offered this option.
authors.affiliation: University of Illinois at Chicago Eye Center, USA.
authors.forename: E
authors.initials: E
authors.lastname: Garcia-Valenzuela
authors.forename: N P
authors.initials: NP
authors.lastname: Blair
authors.forename: M J
authors.initials: MJ
authors.lastname: Shapiro
authors.forename: J P
authors.initials: JP
authors.lastname: Gieser
authors.forename: K I
authors.initials: KI
authors.lastname: Resnick
authors.forename: M J
authors.initials: MJ
authors.lastname: Solomon
authors.forename: J
authors.initials: J
authors.lastname: Sugar
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003316:Corneal Diseases / Q000209:etiology / Q000601:surgery*; D005131:Eye Injuries / Q000150:complications; D005260:Female; D006801:Humans; D015948:Keratoplasty, Penetrating; D008297:Male; D008875:Middle Aged; D019919:Prosthesis Implantation / Q000379:methods*; D012164:Retinal Diseases / Q000209:etiology / Q000601:surgery*; D012189:Retrospective Studies; D012827:Silicone Oils / Q000008:administration & dosage; D016896:Treatment Outcome; D014821:Vitrectomy
chemical_list: D012827:Silicone Oils